Gene Symbol | Gene ID | Gene Info |
---|---|---|
Grhl1
|
ENSMUSG00000020656.9 | grainyhead like transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_24593521_24593681 | Grhl1 | 12852 | 0.165142 | 0.71 | 1.4e-09 | Click! |
chr12_24592948_24593442 | Grhl1 | 12446 | 0.166120 | 0.70 | 3.2e-09 | Click! |
chr12_24584854_24585005 | Grhl1 | 4180 | 0.207943 | -0.52 | 4.6e-05 | Click! |
chr12_24581394_24581564 | Grhl1 | 730 | 0.657143 | -0.39 | 3.0e-03 | Click! |
chr12_24585030_24585181 | Grhl1 | 4356 | 0.205125 | -0.30 | 2.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_5560565_5561137 | 109.89 |
Ovol1 |
ovo like zinc finger 1 |
205 |
0.73 |
chr18_11633021_11633442 | 103.34 |
Rbbp8 |
retinoblastoma binding protein 8, endonuclease |
45 |
0.98 |
chr2_143890129_143890315 | 97.25 |
Gm11686 |
predicted gene 11686 |
9045 |
0.14 |
chr2_128265453_128265624 | 58.20 |
Morrbid |
myeloid RNA regulator of BCL2L11 induced cell death |
24853 |
0.21 |
chr3_101667261_101667482 | 57.93 |
Gm43135 |
predicted gene 43135 |
24418 |
0.18 |
chr2_180289703_180290051 | 57.90 |
Rbbp8nl |
RBBP8 N-terminal like |
2 |
0.96 |
chr5_131898033_131898361 | 54.46 |
Gm42441 |
predicted gene 42441 |
8245 |
0.13 |
chr7_127925119_127925602 | 54.37 |
Prss8 |
protease, serine 8 (prostasin) |
4735 |
0.07 |
chr8_3252706_3253021 | 53.29 |
Gm16180 |
predicted gene 16180 |
6841 |
0.21 |
chr16_22572761_22572964 | 52.62 |
Gm15651 |
predicted gene 15651 |
24309 |
0.11 |
chr4_150825586_150825821 | 52.36 |
Gm13049 |
predicted gene 13049 |
30 |
0.97 |
chr15_88851623_88851810 | 49.97 |
Pim3 |
proviral integration site 3 |
10470 |
0.13 |
chr4_155063996_155064179 | 48.78 |
Pex10 |
peroxisomal biogenesis factor 10 |
2929 |
0.17 |
chr10_125362846_125362997 | 48.40 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
20742 |
0.2 |
chr5_74738329_74738568 | 48.15 |
Gm15985 |
predicted gene 15985 |
3997 |
0.2 |
chr16_95221160_95221311 | 48.01 |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
36323 |
0.15 |
chr5_147870331_147870513 | 47.78 |
Pomp |
proteasome maturation protein |
37 |
0.96 |
chr3_35720813_35721349 | 47.50 |
Gm25696 |
predicted gene, 25696 |
14292 |
0.19 |
chr14_7896220_7896402 | 47.11 |
Flnb |
filamin, beta |
11570 |
0.19 |
chr2_103144443_103144797 | 46.66 |
Gm13874 |
predicted gene 13874 |
33167 |
0.13 |
chr19_3842429_3842615 | 46.44 |
Chka |
choline kinase alpha |
9251 |
0.09 |
chr8_106611054_106611250 | 45.36 |
Cdh1 |
cadherin 1 |
7009 |
0.18 |
chr7_112993039_112993190 | 45.12 |
Gm33586 |
predicted gene, 33586 |
9211 |
0.2 |
chr15_84724297_84724475 | 45.08 |
Gm20556 |
predicted gene, 20556 |
4120 |
0.2 |
chr13_100518273_100518484 | 44.54 |
Gtf2h2 |
general transcription factor II H, polypeptide 2 |
25799 |
0.1 |
chr7_107686020_107686216 | 43.90 |
Ppfibp2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
20807 |
0.15 |
chr8_11176492_11176643 | 43.54 |
Gm15418 |
predicted gene 15418 |
11188 |
0.16 |
chr15_76881362_76881517 | 43.50 |
Gm49527 |
predicted gene, 49527 |
2005 |
0.16 |
chr2_128722229_128722389 | 43.29 |
Mertk |
MER proto-oncogene tyrosine kinase |
23353 |
0.13 |
chr16_54346201_54346376 | 43.23 |
Gm49639 |
predicted gene, 49639 |
4040 |
0.29 |
chr10_29285902_29286053 | 43.13 |
Echdc1 |
enoyl Coenzyme A hydratase domain containing 1 |
27189 |
0.12 |
chr2_154651444_154651613 | 42.94 |
Chmp4b |
charged multivesicular body protein 4B |
177 |
0.92 |
chr11_59218421_59218612 | 42.79 |
Arf1 |
ADP-ribosylation factor 1 |
9646 |
0.09 |
chr13_54675990_54676160 | 42.34 |
Rnf44 |
ring finger protein 44 |
7997 |
0.13 |
chr7_141338823_141339022 | 42.23 |
Eps8l2 |
EPS8-like 2 |
34 |
0.94 |
chr2_4829814_4829999 | 42.22 |
Gm13176 |
predicted gene 13176 |
4706 |
0.22 |
chr8_117124308_117124738 | 42.09 |
Gm20694 |
predicted gene 20694 |
812 |
0.6 |
chr15_37313032_37313209 | 42.09 |
Grhl2 |
grainyhead like transcription factor 2 |
5283 |
0.17 |
chr5_115436438_115437458 | 41.71 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr7_65213256_65213540 | 41.44 |
1810049I09Rik |
RIKEN cDNA 1810049I09 gene |
29 |
0.98 |
chr16_89954597_89954798 | 40.81 |
Tiam1 |
T cell lymphoma invasion and metastasis 1 |
1410 |
0.55 |
chr11_100386713_100386920 | 40.39 |
Jup |
junction plakoglobin |
46 |
0.94 |
chr11_42939394_42939593 | 40.22 |
Gm9972 |
predicted gene 9972 |
96253 |
0.08 |
chr4_63032553_63033019 | 39.97 |
Zfp618 |
zinc finger protein 618 |
67212 |
0.09 |
chr3_121865203_121865377 | 39.87 |
Gm42593 |
predicted gene 42593 |
2448 |
0.25 |
chr11_121544033_121544254 | 39.67 |
Tbcd |
tubulin-specific chaperone d |
58 |
0.98 |
chr8_35946633_35946808 | 39.63 |
Gm22030 |
predicted gene, 22030 |
30858 |
0.16 |
chr11_106896669_106896820 | 38.40 |
Smurf2 |
SMAD specific E3 ubiquitin protein ligase 2 |
23531 |
0.13 |
chr1_60609474_60609750 | 38.30 |
Gm23762 |
predicted gene, 23762 |
4191 |
0.16 |
chr10_18194948_18195136 | 38.28 |
Ect2l |
epithelial cell transforming sequence 2 oncogene-like |
6311 |
0.19 |
chr1_96805556_96805715 | 38.23 |
Gm26078 |
predicted gene, 26078 |
43604 |
0.15 |
chr19_7334185_7334348 | 38.22 |
Mark2 |
MAP/microtubule affinity regulating kinase 2 |
6926 |
0.12 |
chr7_80779147_80779764 | 38.19 |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
23808 |
0.14 |
chr9_21337737_21337910 | 37.67 |
Slc44a2 |
solute carrier family 44, member 2 |
5 |
0.95 |
chr2_128240637_128240809 | 37.50 |
Morrbid |
myeloid RNA regulator of BCL2L11 induced cell death |
38 |
0.98 |
chr6_125368207_125368362 | 37.44 |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
7857 |
0.13 |
chr13_3832113_3832266 | 37.41 |
Calm4 |
calmodulin 4 |
5568 |
0.13 |
chr11_53143670_53143821 | 37.38 |
Gm11186 |
predicted gene 11186 |
23689 |
0.2 |
chr8_93229541_93229729 | 37.04 |
Ces1e |
carboxylesterase 1E |
16 |
0.97 |
chr15_36852330_36852518 | 36.80 |
Gm49282 |
predicted gene, 49282 |
9608 |
0.16 |
chr9_115356751_115357118 | 36.72 |
Mir467h |
microRNA 467h |
24885 |
0.11 |
chr10_128584524_128584710 | 36.25 |
Mir6917 |
microRNA 6917 |
120 |
0.89 |
chr1_135227429_135227603 | 36.04 |
Gm4204 |
predicted gene 4204 |
4479 |
0.14 |
chr9_78347050_78347288 | 35.82 |
Gsta2 |
glutathione S-transferase, alpha 2 (Yc2) |
1 |
0.95 |
chr13_3644972_3645195 | 35.49 |
Gm23084 |
predicted gene, 23084 |
3454 |
0.2 |
chr11_96928787_96928959 | 35.48 |
Prr15l |
proline rich 15-like |
429 |
0.67 |
chr14_79527720_79528017 | 35.45 |
Elf1 |
E74-like factor 1 |
12170 |
0.16 |
chr1_171370271_171370445 | 35.42 |
Nectin4 |
nectin cell adhesion molecule 4 |
3 |
0.93 |
chr1_20863557_20864084 | 35.28 |
Gm24723 |
predicted gene, 24723 |
21154 |
0.1 |
chr11_115174043_115174226 | 35.16 |
Slc9a3r1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 |
10793 |
0.11 |
chr17_83699447_83699608 | 34.98 |
Mta3 |
metastasis associated 3 |
6636 |
0.26 |
chr18_43724967_43725126 | 34.51 |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
12511 |
0.18 |
chr11_90678668_90678836 | 34.50 |
Tom1l1 |
target of myb1-like 1 (chicken) |
8827 |
0.21 |
chr7_28577867_28578108 | 34.49 |
Pak4 |
p21 (RAC1) activated kinase 4 |
9750 |
0.08 |
chr13_24849504_24849661 | 34.29 |
D130043K22Rik |
RIKEN cDNA D130043K22 gene |
4447 |
0.15 |
chr18_74536326_74536583 | 34.19 |
1700120E14Rik |
RIKEN cDNA 1700120E14 gene |
5330 |
0.27 |
chr13_37507156_37507457 | 34.14 |
Gm47734 |
predicted gene, 47734 |
446 |
0.67 |
chr2_160353650_160353840 | 34.07 |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
13320 |
0.23 |
chr4_150825010_150825241 | 33.91 |
Gm13049 |
predicted gene 13049 |
608 |
0.69 |
chr5_144507241_144507405 | 33.72 |
Nptx2 |
neuronal pentraxin 2 |
38579 |
0.17 |
chr6_135304673_135304824 | 33.70 |
Pbp2 |
phosphatidylethanolamine binding protein 2 |
5657 |
0.13 |
chr2_20547399_20547676 | 33.50 |
Etl4 |
enhancer trap locus 4 |
443 |
0.9 |
chr13_37908190_37908412 | 33.38 |
Rreb1 |
ras responsive element binding protein 1 |
19430 |
0.2 |
chr2_69630868_69631190 | 33.28 |
Bbs5 |
Bardet-Biedl syndrome 5 (human) |
16142 |
0.16 |
chr17_87635720_87636021 | 33.22 |
Epcam |
epithelial cell adhesion molecule |
109 |
0.97 |
chr8_33964101_33964274 | 33.15 |
Gm39157 |
predicted gene, 39157 |
21727 |
0.14 |
chr2_127541395_127541583 | 33.01 |
Prom2 |
prominin 2 |
22 |
0.96 |
chr11_116260472_116260655 | 32.78 |
Srp68 |
signal recognition particle 68 |
775 |
0.45 |
chr9_92865919_92866132 | 32.75 |
Gm28054 |
predicted gene 28054 |
29807 |
0.21 |
chr3_142863374_142863525 | 32.13 |
Pkn2 |
protein kinase N2 |
7714 |
0.14 |
chr3_53687905_53688064 | 32.01 |
Gm6204 |
predicted gene 6204 |
4894 |
0.16 |
chr7_44662273_44662451 | 31.72 |
Myh14 |
myosin, heavy polypeptide 14 |
3139 |
0.12 |
chr9_70888692_70888862 | 31.49 |
Gm3436 |
predicted pseudogene 3436 |
36201 |
0.14 |
chr7_29512829_29512980 | 31.28 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
5651 |
0.16 |
chr9_90277992_90278184 | 31.20 |
Tbc1d2b |
TBC1 domain family, member 2B |
7284 |
0.17 |
chr16_48603814_48604189 | 30.86 |
Morc1 |
microrchidia 1 |
9334 |
0.27 |
chr18_84858582_84858897 | 30.77 |
Gm16146 |
predicted gene 16146 |
808 |
0.57 |
chr1_130770429_130770755 | 30.64 |
Gm28856 |
predicted gene 28856 |
4208 |
0.12 |
chr9_116270473_116270624 | 30.63 |
Gm31410 |
predicted gene, 31410 |
51746 |
0.12 |
chr1_39410534_39410685 | 30.58 |
Gm37265 |
predicted gene, 37265 |
9323 |
0.16 |
chr2_57454391_57454615 | 30.44 |
Gm13531 |
predicted gene 13531 |
28794 |
0.23 |
chr5_144978860_144979051 | 30.44 |
Smurf1 |
SMAD specific E3 ubiquitin protein ligase 1 |
13108 |
0.12 |
chr2_165909846_165909997 | 30.26 |
Gm22692 |
predicted gene, 22692 |
1746 |
0.26 |
chr14_99305409_99305608 | 30.12 |
Klf5 |
Kruppel-like factor 5 |
6354 |
0.17 |
chr1_118650027_118650214 | 30.12 |
Gm28882 |
predicted gene 28882 |
1675 |
0.31 |
chr11_78247114_78247265 | 29.96 |
Supt6 |
SPT6, histone chaperone and transcription elongation factor |
1202 |
0.22 |
chr12_83105617_83105798 | 29.88 |
Rgs6 |
regulator of G-protein signaling 6 |
1080 |
0.47 |
chr4_59434167_59434351 | 29.86 |
Susd1 |
sushi domain containing 1 |
4374 |
0.24 |
chr3_108476837_108477244 | 29.64 |
5330417C22Rik |
RIKEN cDNA 5330417C22 gene |
6959 |
0.1 |
chr6_15720002_15720320 | 29.50 |
Mdfic |
MyoD family inhibitor domain containing |
500 |
0.86 |
chr2_103303292_103303466 | 29.40 |
Ehf |
ets homologous factor |
101 |
0.97 |
chr13_52151935_52152125 | 29.35 |
Gm48199 |
predicted gene, 48199 |
28381 |
0.19 |
chr4_142221224_142221954 | 29.33 |
Kazn |
kazrin, periplakin interacting protein |
11383 |
0.22 |
chr4_134065688_134065884 | 29.19 |
Crybg2 |
crystallin beta-gamma domain containing 2 |
126 |
0.93 |
chr2_118586131_118586282 | 28.99 |
Gm14016 |
predicted gene 14016 |
7873 |
0.16 |
chrX_100802172_100802323 | 28.94 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
5670 |
0.21 |
chr4_95068422_95068577 | 28.69 |
n-R5s189 |
nuclear encoded rRNA 5S 189 |
5849 |
0.13 |
chr4_150306789_150306940 | 28.65 |
Gm13092 |
predicted gene 13092 |
8572 |
0.16 |
chr6_138143543_138143744 | 28.63 |
Mgst1 |
microsomal glutathione S-transferase 1 |
789 |
0.75 |
chr17_79728677_79729124 | 28.43 |
Gm33055 |
predicted gene, 33055 |
4974 |
0.18 |
chr6_5306099_5306308 | 27.97 |
Pon2 |
paraoxonase 2 |
7748 |
0.2 |
chr10_18350892_18351043 | 27.93 |
Gm18942 |
predicted gene, 18942 |
13726 |
0.19 |
chr15_83167234_83167461 | 27.82 |
Cyb5r3 |
cytochrome b5 reductase 3 |
2830 |
0.15 |
chr11_66960715_66961066 | 27.75 |
Tmem238l |
transmembrane protein 238 like |
2996 |
0.21 |
chr9_22405515_22405666 | 27.62 |
Gm48652 |
predicted gene, 48652 |
4004 |
0.13 |
chr11_5240415_5240622 | 27.54 |
Kremen1 |
kringle containing transmembrane protein 1 |
2070 |
0.29 |
chr9_107279220_107279394 | 27.39 |
Mapkapk3 |
mitogen-activated protein kinase-activated protein kinase 3 |
1608 |
0.22 |
chr13_24272885_24273036 | 27.26 |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
7526 |
0.14 |
chr16_96361281_96361506 | 27.25 |
Igsf5 |
immunoglobulin superfamily, member 5 |
275 |
0.62 |
chr4_141242666_141243068 | 27.22 |
Arhgef19 |
Rho guanine nucleotide exchange factor (GEF) 19 |
2 |
0.96 |
chr19_55271538_55271750 | 27.22 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
1226 |
0.45 |
chr7_75585484_75585685 | 27.21 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
24455 |
0.17 |
chr1_67000582_67000809 | 27.21 |
Lancl1 |
LanC (bacterial lantibiotic synthetase component C)-like 1 |
20370 |
0.15 |
chr6_100297681_100297841 | 27.11 |
Rybp |
RING1 and YY1 binding protein |
10276 |
0.18 |
chr11_72406403_72406587 | 27.05 |
Smtnl2 |
smoothelin-like 2 |
3387 |
0.16 |
chr5_28495762_28495935 | 26.94 |
Shh |
sonic hedgehog |
28592 |
0.16 |
chr11_86390434_86390598 | 26.81 |
Gm23667 |
predicted gene, 23667 |
18310 |
0.17 |
chr4_63625897_63626059 | 26.71 |
Tex48 |
testis expressed 48 |
3550 |
0.15 |
chr17_5893214_5893395 | 26.66 |
Gm8376 |
predicted gene 8376 |
45783 |
0.1 |
chr15_80159254_80159657 | 26.60 |
Mgat3 |
mannoside acetylglucosaminyltransferase 3 |
14266 |
0.11 |
chr13_114680541_114680791 | 26.59 |
4930544M13Rik |
RIKEN cDNA 4930544M13 gene |
73429 |
0.09 |
chr1_136220271_136220474 | 26.58 |
Gm26568 |
predicted gene, 26568 |
4298 |
0.12 |
chr15_85519541_85519738 | 26.49 |
Gm4825 |
predicted pseudogene 4825 |
8827 |
0.17 |
chr1_10253942_10254168 | 26.33 |
Arfgef1 |
ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) |
21385 |
0.21 |
chr4_95389787_95390075 | 26.16 |
Gm29064 |
predicted gene 29064 |
12859 |
0.24 |
chr9_20971774_20972514 | 26.12 |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
1834 |
0.17 |
chr4_41284196_41284347 | 25.85 |
Ubap2 |
ubiquitin-associated protein 2 |
9127 |
0.1 |
chr14_75136222_75136373 | 25.77 |
Lcp1 |
lymphocyte cytosolic protein 1 |
35 |
0.92 |
chr14_120313576_120313747 | 25.71 |
Mbnl2 |
muscleblind like splicing factor 2 |
7205 |
0.27 |
chr4_138983515_138983717 | 25.64 |
Tmco4 |
transmembrane and coiled-coil domains 4 |
10707 |
0.15 |
chr2_167839366_167839651 | 25.55 |
1200007C13Rik |
RIKEN cDNA 1200007C13 gene |
5862 |
0.17 |
chr10_67174188_67174339 | 25.53 |
Jmjd1c |
jumonji domain containing 1C |
11485 |
0.21 |
chr7_142434236_142434421 | 25.51 |
Syt8 |
synaptotagmin VIII |
522 |
0.63 |
chr4_57339041_57339192 | 25.35 |
1700042G15Rik |
RIKEN cDNA 1700042G15 gene |
25136 |
0.14 |
chr2_91474390_91474738 | 25.29 |
Lrp4 |
low density lipoprotein receptor-related protein 4 |
1692 |
0.32 |
chr3_94784227_94784426 | 25.29 |
Cgn |
cingulin |
2125 |
0.21 |
chr5_17271802_17272025 | 25.17 |
Gm6673 |
predicted gene 6673 |
43979 |
0.18 |
chr4_149314416_149314567 | 25.15 |
Kif1b |
kinesin family member 1B |
6798 |
0.14 |
chr12_79041477_79041656 | 25.15 |
Plekhh1 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
5930 |
0.16 |
chr10_13328717_13328879 | 24.89 |
Phactr2 |
phosphatase and actin regulator 2 |
4509 |
0.3 |
chr2_77303060_77303225 | 24.83 |
Gm13943 |
predicted gene 13943 |
11609 |
0.15 |
chr4_99141637_99141887 | 24.62 |
Gm12681 |
predicted gene 12681 |
19880 |
0.13 |
chr7_19724296_19724447 | 24.46 |
Tomm40 |
translocase of outer mitochondrial membrane 40 |
8933 |
0.07 |
chr19_41794132_41794283 | 24.35 |
Arhgap19 |
Rho GTPase activating protein 19 |
7840 |
0.17 |
chr17_26384281_26384432 | 24.33 |
Neurl1b |
neuralized E3 ubiquitin protein ligase 1B |
30473 |
0.11 |
chr2_144332070_144332234 | 24.33 |
Ovol2 |
ovo like zinc finger 2 |
6 |
0.92 |
chr10_78138888_78139072 | 24.09 |
Gm47922 |
predicted gene, 47922 |
883 |
0.48 |
chr15_99835240_99835516 | 24.06 |
Lima1 |
LIM domain and actin binding 1 |
15235 |
0.08 |
chr17_56907192_56907389 | 24.03 |
Mllt1 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1 |
1069 |
0.38 |
chr1_171477986_171478264 | 23.87 |
F11r |
F11 receptor |
15275 |
0.08 |
chr3_88548183_88548477 | 23.82 |
Rab25 |
RAB25, member RAS oncogene family |
30 |
0.93 |
chr15_37232860_37233389 | 23.72 |
Gm16136 |
predicted gene 16136 |
17 |
0.53 |
chr7_117505916_117506067 | 23.65 |
Xylt1 |
xylosyltransferase 1 |
30499 |
0.24 |
chr18_4970958_4971172 | 23.63 |
Svil |
supervillin |
22748 |
0.26 |
chr1_37615254_37615585 | 23.63 |
4930556I23Rik |
RIKEN cDNA 4930556I23 gene |
1160 |
0.45 |
chr11_5908769_5908960 | 23.58 |
Gck |
glucokinase |
6260 |
0.12 |
chr4_141130814_141131008 | 23.51 |
Szrd1 |
SUZ RNA binding domain containing 1 |
8816 |
0.11 |
chr2_118544169_118545221 | 23.48 |
Bmf |
BCL2 modifying factor |
108 |
0.96 |
chr1_53845996_53846147 | 23.47 |
Mir7681 |
microRNA 7681 |
3353 |
0.22 |
chr1_93157749_93157900 | 23.44 |
Mab21l4 |
mab-21-like 4 |
3046 |
0.17 |
chr12_73206351_73206524 | 23.38 |
Gm23910 |
predicted gene, 23910 |
60532 |
0.1 |
chr3_152121980_152122490 | 23.35 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
13713 |
0.13 |
chrX_73576478_73576629 | 23.33 |
Gm9730 |
predicted gene 9730 |
7570 |
0.16 |
chr14_99605421_99605621 | 23.26 |
Gm49225 |
predicted gene, 49225 |
14495 |
0.2 |
chr9_87148052_87148208 | 23.18 |
Mrap2 |
melanocortin 2 receptor accessory protein 2 |
3787 |
0.2 |
chr15_37197944_37198256 | 23.17 |
Gm8664 |
predicted gene 8664 |
15399 |
0.14 |
chr12_57663416_57663567 | 23.11 |
BC042761 |
cDNA sequence BC042761 |
580 |
0.71 |
chr2_29768107_29768273 | 23.06 |
Gm13547 |
predicted gene 13547 |
6629 |
0.1 |
chr13_108498472_108498692 | 22.87 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
48573 |
0.17 |
chr10_80106019_80106211 | 22.75 |
Sbno2 |
strawberry notch 2 |
544 |
0.58 |
chr10_91953216_91953385 | 22.73 |
Gm31592 |
predicted gene, 31592 |
64471 |
0.13 |
chr1_161444915_161445196 | 22.62 |
Tnfsf18 |
tumor necrosis factor (ligand) superfamily, member 18 |
49600 |
0.12 |
chr5_121454238_121454474 | 22.61 |
Tmem116 |
transmembrane protein 116 |
1047 |
0.31 |
chr7_121779137_121779288 | 22.59 |
Scnn1g |
sodium channel, nonvoltage-gated 1 gamma |
44733 |
0.12 |
chr19_25856398_25856710 | 22.56 |
Gm8825 |
predicted gene 8825 |
59747 |
0.15 |
chr3_38415663_38415818 | 22.43 |
3830422I06Rik |
RIKEN cDNA 3830422I06 gene |
4411 |
0.19 |
chr6_120195102_120195265 | 22.33 |
Ninj2 |
ninjurin 2 |
1360 |
0.46 |
chr16_30441473_30441767 | 22.32 |
Gm49679 |
predicted gene, 49679 |
10968 |
0.2 |
chr3_84637990_84638158 | 22.29 |
Tmem154 |
transmembrane protein 154 |
28118 |
0.16 |
chr13_45088873_45089068 | 22.17 |
Hsp25-ps1 |
heat shock protein 25, pseudogene 1 |
9843 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.3 | 101.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
12.2 | 36.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
9.9 | 39.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
9.8 | 39.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
8.4 | 41.9 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
8.3 | 24.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
8.2 | 32.6 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
7.3 | 43.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
7.2 | 21.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
7.1 | 14.3 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
5.7 | 22.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
5.2 | 83.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
5.2 | 15.6 | GO:0061198 | fungiform papilla formation(GO:0061198) |
5.2 | 20.7 | GO:0060214 | endocardium formation(GO:0060214) |
4.9 | 9.8 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
4.7 | 14.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
4.7 | 14.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
4.7 | 14.0 | GO:0070268 | cornification(GO:0070268) |
4.3 | 52.1 | GO:0043248 | proteasome assembly(GO:0043248) |
4.1 | 20.5 | GO:0021603 | cranial nerve formation(GO:0021603) |
3.6 | 14.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
3.5 | 14.0 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
3.4 | 27.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
3.4 | 10.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
3.3 | 16.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
3.3 | 9.8 | GO:1903011 | negative regulation of bone development(GO:1903011) |
3.2 | 9.6 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
3.2 | 12.7 | GO:0010288 | response to lead ion(GO:0010288) |
3.1 | 9.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.0 | 21.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
2.8 | 8.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
2.6 | 7.9 | GO:0021571 | rhombomere 5 development(GO:0021571) |
2.5 | 12.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
2.5 | 12.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
2.4 | 7.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
2.4 | 7.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.4 | 7.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
2.3 | 6.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
2.3 | 9.2 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.3 | 6.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
2.2 | 24.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
2.1 | 4.3 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.1 | 25.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
2.1 | 8.5 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
2.1 | 6.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
2.1 | 27.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
2.0 | 8.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.0 | 29.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
2.0 | 6.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.9 | 3.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.9 | 5.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.9 | 9.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.8 | 14.7 | GO:0051014 | actin filament severing(GO:0051014) |
1.8 | 5.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.8 | 5.4 | GO:0050904 | diapedesis(GO:0050904) |
1.8 | 30.3 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
1.7 | 5.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.7 | 5.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.7 | 1.7 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
1.7 | 3.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.7 | 5.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.7 | 11.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.6 | 9.8 | GO:0044351 | macropinocytosis(GO:0044351) |
1.6 | 8.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
1.6 | 3.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.6 | 4.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.5 | 3.0 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
1.5 | 3.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.5 | 10.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
1.4 | 2.9 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
1.4 | 4.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.4 | 4.3 | GO:1903416 | response to glycoside(GO:1903416) |
1.4 | 8.5 | GO:0071800 | podosome assembly(GO:0071800) |
1.4 | 8.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.4 | 5.6 | GO:0003383 | apical constriction(GO:0003383) |
1.4 | 17.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
1.4 | 6.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.3 | 5.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.3 | 2.6 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.3 | 5.3 | GO:0051031 | tRNA transport(GO:0051031) |
1.3 | 1.3 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.3 | 11.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.3 | 5.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.3 | 3.9 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.3 | 3.9 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.3 | 6.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.3 | 3.8 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.3 | 17.9 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
1.2 | 6.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.2 | 4.9 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.2 | 4.8 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.2 | 3.6 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.2 | 1.2 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
1.2 | 2.4 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
1.2 | 4.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.2 | 1.2 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
1.2 | 3.5 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.1 | 3.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.1 | 3.4 | GO:0040031 | snRNA modification(GO:0040031) |
1.1 | 5.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.1 | 5.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.1 | 4.5 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.1 | 4.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.1 | 1.1 | GO:0042117 | monocyte activation(GO:0042117) |
1.1 | 2.2 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
1.1 | 1.1 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.1 | 3.3 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.1 | 3.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.1 | 10.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.1 | 2.2 | GO:0070836 | caveola assembly(GO:0070836) |
1.1 | 3.2 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.1 | 5.4 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
1.1 | 4.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.1 | 3.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.1 | 1.1 | GO:0061346 | cardiac right atrium morphogenesis(GO:0003213) non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.1 | 11.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.1 | 2.1 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.1 | 2.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.0 | 2.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.0 | 4.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.0 | 2.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.0 | 4.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.0 | 3.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.0 | 1.0 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
1.0 | 3.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.0 | 3.0 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.0 | 7.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.0 | 40.9 | GO:0046718 | viral entry into host cell(GO:0046718) |
1.0 | 1.0 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
1.0 | 10.9 | GO:0003334 | keratinocyte development(GO:0003334) |
1.0 | 3.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.0 | 3.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.0 | 7.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.0 | 3.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.9 | 1.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.9 | 2.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.9 | 1.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.9 | 0.9 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.9 | 3.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.9 | 18.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.9 | 9.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.9 | 1.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.9 | 15.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.9 | 5.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.9 | 2.7 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 0.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 0.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.9 | 3.6 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.9 | 3.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.9 | 1.8 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.9 | 19.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.9 | 0.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.9 | 2.6 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.9 | 3.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.9 | 5.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.9 | 4.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.9 | 1.7 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.9 | 2.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.8 | 3.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.8 | 4.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.8 | 2.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.8 | 2.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 1.7 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.8 | 5.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.8 | 1.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.8 | 1.6 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.8 | 0.8 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.8 | 3.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.8 | 8.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.8 | 2.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.8 | 20.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.8 | 2.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.8 | 4.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.8 | 7.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.8 | 3.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.8 | 2.4 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.8 | 4.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.8 | 5.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.8 | 6.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.8 | 4.7 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.8 | 4.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.8 | 8.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.8 | 3.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.8 | 3.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.8 | 1.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.8 | 4.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.8 | 9.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.8 | 1.5 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.7 | 5.2 | GO:0060613 | fat pad development(GO:0060613) |
0.7 | 8.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.7 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.7 | 4.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 3.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.7 | 2.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.7 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.7 | 0.7 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.7 | 5.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.7 | 7.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.7 | 3.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.7 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.7 | 0.7 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.7 | 5.0 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.7 | 5.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.7 | 0.7 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.7 | 2.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.7 | 2.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 15.4 | GO:0014823 | response to activity(GO:0014823) |
0.7 | 5.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.7 | 0.7 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.7 | 4.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.7 | 0.7 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.7 | 2.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.7 | 16.5 | GO:0043297 | apical junction assembly(GO:0043297) |
0.7 | 0.7 | GO:0036258 | multivesicular body assembly(GO:0036258) late endosomal microautophagy(GO:0061738) |
0.7 | 0.7 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.7 | 10.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.7 | 2.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.7 | 1.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.7 | 2.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.7 | 4.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.7 | 1.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.7 | 1.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.7 | 2.0 | GO:0002432 | granuloma formation(GO:0002432) |
0.7 | 2.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.7 | 4.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.6 | 0.6 | GO:0018214 | protein carboxylation(GO:0018214) |
0.6 | 1.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.6 | 0.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.6 | 1.9 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.6 | 1.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.6 | 1.9 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 1.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.6 | 1.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.6 | 1.3 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.6 | 1.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.6 | 0.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.6 | 1.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 0.6 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.6 | 1.9 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.6 | 3.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.6 | 2.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.6 | 3.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.6 | 6.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.6 | 2.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.6 | 1.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 1.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 7.2 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.6 | 5.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.6 | 2.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 4.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.6 | 1.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 7.7 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.6 | 1.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 5.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.6 | 1.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.6 | 4.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.6 | 57.9 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.6 | 1.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.6 | 1.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.6 | 0.6 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.6 | 6.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.6 | 18.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.6 | 1.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.6 | 0.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.6 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 1.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.6 | 0.6 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.6 | 1.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.6 | 1.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.6 | 2.3 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.6 | 1.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.6 | 1.7 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.6 | 2.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.6 | 3.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 1.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 0.6 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.6 | 7.8 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.6 | 5.5 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.6 | 4.4 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.5 | 18.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.5 | 10.4 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 2.2 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.5 | 2.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.5 | 1.6 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.5 | 1.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 1.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.5 | 7.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.5 | 7.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.5 | 2.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 2.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 7.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.5 | 4.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 4.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.5 | 1.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.5 | 1.6 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.5 | 3.2 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 57.0 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.5 | 3.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.5 | 0.5 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.5 | 0.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.5 | 1.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.5 | 1.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.5 | 0.5 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.5 | 1.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.5 | 2.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 7.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 2.6 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 1.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 1.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 6.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 2.5 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.5 | 3.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.5 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 1.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 1.0 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 4.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 1.5 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.5 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 2.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 7.0 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.5 | 0.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.5 | 2.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 15.9 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.5 | 1.0 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.5 | 0.5 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.5 | 5.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 3.4 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.5 | 3.9 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.5 | 2.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 1.0 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
0.5 | 1.9 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.5 | 1.0 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.5 | 1.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 0.9 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.5 | 0.5 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.5 | 0.9 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.5 | 2.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.5 | 5.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.5 | 0.5 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.5 | 2.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 2.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.5 | 1.8 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.5 | 2.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.5 | 3.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 1.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 3.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.5 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 2.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 1.4 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.5 | 2.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 0.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.5 | 1.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 0.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.5 | 1.8 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
0.4 | 3.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 0.9 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.4 | 1.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.4 | 2.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 0.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 2.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.4 | 1.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 0.9 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 0.9 | GO:0009838 | abscission(GO:0009838) |
0.4 | 0.4 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.4 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 3.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 0.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.4 | 0.4 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 1.3 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.4 | 1.7 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 3.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.4 | 2.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 2.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 11.6 | GO:0042246 | tissue regeneration(GO:0042246) |
0.4 | 0.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 1.3 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.4 | 0.4 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.4 | 1.7 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.4 | 3.0 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.4 | 5.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.4 | 1.7 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 3.3 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.4 | 0.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.4 | 1.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 1.2 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 0.8 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.4 | 1.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 3.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.4 | 1.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 0.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.4 | 1.2 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 1.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 1.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 1.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 0.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 1.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 1.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 1.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 0.4 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.4 | 0.8 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.4 | 0.8 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.4 | 1.2 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.4 | 1.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 1.2 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.4 | 2.7 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.4 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.4 | 0.4 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.4 | 7.6 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.4 | 0.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 0.8 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
0.4 | 3.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.4 | 0.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 4.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 1.9 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.4 | 3.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.4 | 0.4 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.4 | 1.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.4 | 4.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 2.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.4 | 0.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.4 | 3.3 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.4 | 1.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 2.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 1.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 5.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 2.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.4 | 2.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.4 | 0.4 | GO:0034311 | diol metabolic process(GO:0034311) |
0.4 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.4 | 0.4 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.4 | 0.4 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.4 | 1.8 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.4 | 0.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 2.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.4 | 0.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.4 | 1.8 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.4 | 3.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 9.2 | GO:0031424 | keratinization(GO:0031424) |
0.4 | 2.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.4 | 2.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 3.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.4 | 1.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 1.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 3.1 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.3 | 1.0 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.3 | 1.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 0.3 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 2.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.3 | 0.3 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.3 | 2.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.3 | 0.7 | GO:0090500 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.3 | 3.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.3 | 1.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 0.7 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.3 | 0.7 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.3 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 0.3 | GO:2000562 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 6.5 | GO:0097009 | energy homeostasis(GO:0097009) |
0.3 | 0.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 1.7 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 2.0 | GO:0007569 | cell aging(GO:0007569) |
0.3 | 1.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 2.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 1.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 0.7 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.3 | 1.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.3 | 1.6 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.3 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 3.3 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.3 | 3.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.3 | 2.3 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.3 | 1.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.3 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 0.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 5.8 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.3 | 2.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.3 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.3 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 1.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 1.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.6 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.3 | 1.9 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 16.4 | GO:0034329 | cell junction assembly(GO:0034329) |
0.3 | 1.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 0.3 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.3 | 1.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.3 | 2.9 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.3 | 15.6 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.3 | 3.5 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.3 | 1.9 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.3 | 1.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 7.0 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.3 | 6.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 0.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.3 | GO:0042347 | cytoplasmic sequestering of NF-kappaB(GO:0007253) negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 2.2 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.3 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 1.9 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.3 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.5 | GO:0014741 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.3 | 0.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 0.3 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 0.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.3 | 2.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 0.6 | GO:0019081 | viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
0.3 | 0.9 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 0.6 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.3 | 0.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 0.9 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.3 | 1.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 1.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.3 | 0.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 0.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.3 | 2.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 3.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 0.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.3 | 1.5 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.3 | 0.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 2.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 0.6 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.3 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 1.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 11.7 | GO:0003341 | cilium movement(GO:0003341) |
0.3 | 1.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 0.6 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.3 | 3.8 | GO:0051642 | centrosome localization(GO:0051642) |
0.3 | 0.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 2.3 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.3 | 0.3 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.3 | 1.4 | GO:0033572 | transferrin transport(GO:0033572) |
0.3 | 33.7 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.3 | 0.3 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.3 | 4.0 | GO:0060325 | face morphogenesis(GO:0060325) |
0.3 | 0.9 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 0.3 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.3 | 2.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 2.2 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.3 | 0.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.3 | 1.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 1.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.3 | 2.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 2.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 3.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 2.5 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.3 | 1.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 9.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.3 | 1.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.3 | 0.5 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.3 | 3.8 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.3 | 1.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.5 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 1.1 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.3 | 0.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.3 | 1.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 1.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 0.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.3 | 0.5 | GO:0019740 | nitrogen utilization(GO:0019740) ammonium transmembrane transport(GO:0072488) |
0.3 | 1.1 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 3.0 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.3 | 1.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.5 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.3 | 1.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.3 | 0.8 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 0.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.3 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 1.1 | GO:0007567 | parturition(GO:0007567) |
0.3 | 4.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.3 | 2.3 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) skeletal muscle adaptation(GO:0043501) |
0.3 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 1.8 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.3 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 1.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 0.5 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 2.1 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 0.5 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 1.3 | GO:0060039 | pericardium development(GO:0060039) |
0.3 | 2.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 0.5 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.3 | 1.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 5.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 3.5 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.3 | 1.8 | GO:0046541 | saliva secretion(GO:0046541) |
0.3 | 1.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 1.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 1.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.3 | 0.8 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.3 | 1.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.5 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 6.7 | GO:0034644 | cellular response to UV(GO:0034644) |
0.2 | 4.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.2 | 1.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.7 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.5 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.2 | 0.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 2.2 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 1.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 3.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 1.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 1.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 2.2 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 0.5 | GO:0046959 | habituation(GO:0046959) |
0.2 | 0.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 1.4 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.2 | 3.4 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.2 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.2 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) |
0.2 | 3.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.7 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.2 | 2.1 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.2 | 4.8 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.2 | 0.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.7 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 8.5 | GO:0001889 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
0.2 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 6.4 | GO:2000107 | negative regulation of leukocyte apoptotic process(GO:2000107) |
0.2 | 1.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 4.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 5.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 1.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 3.5 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.9 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.7 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 1.4 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 3.5 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 0.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 1.6 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.2 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 6.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.5 | GO:1990182 | exosomal secretion(GO:1990182) |
0.2 | 0.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 10.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 1.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 1.8 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.2 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 0.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 2.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 0.9 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 1.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.2 | 0.4 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 0.2 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.2 | 0.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 1.3 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.2 | 0.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 1.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.2 | 3.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.4 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 0.2 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.2 | 1.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.4 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.2 | 1.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 1.0 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.2 | 0.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 2.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 0.4 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.6 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 3.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 2.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 2.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 1.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 1.6 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 2.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 1.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 0.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 2.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 1.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 1.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.2 | 0.2 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.2 | 1.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 0.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 1.9 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 2.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.7 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.2 | 2.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.6 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 1.6 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.4 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.2 | 1.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.5 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.2 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.5 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 2.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.2 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 2.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 1.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.4 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.2 | 1.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.2 | 10.4 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 2.1 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.2 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 2.3 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 0.9 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.2 | 1.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 1.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.5 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.2 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.3 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 1.7 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 1.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 3.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.3 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.2 | 0.9 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
0.2 | 2.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 2.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 2.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 2.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 2.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.7 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) |
0.2 | 2.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.5 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 0.7 | GO:0072678 | T cell migration(GO:0072678) |
0.2 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.2 | GO:0071397 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.2 | 0.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 1.0 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 1.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.2 | 2.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.2 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.2 | 0.6 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 1.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 3.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.2 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.8 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 1.4 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.2 | 1.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 2.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.9 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.2 | 0.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 6.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 0.5 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 3.4 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.2 | 0.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.2 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.2 | 0.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.2 | 0.9 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 0.6 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.3 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 0.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 1.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 3.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.3 | GO:0039533 | MDA-5 signaling pathway(GO:0039530) regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 2.4 | GO:0051591 | response to cAMP(GO:0051591) |
0.2 | 0.6 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.2 | 0.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.2 | 0.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.9 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.3 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 1.2 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.6 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.6 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 1.4 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 0.6 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.4 | GO:0097205 | renal filtration(GO:0097205) |
0.1 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 1.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.6 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.1 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 0.4 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.3 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.6 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 2.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.3 | GO:2000319 | positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.7 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 1.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.3 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.3 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 1.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 1.2 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 1.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.4 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.4 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.1 | GO:0071726 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.1 | 0.1 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 1.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.6 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 10.5 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.1 | 0.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.4 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.6 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.4 | GO:0070197 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 1.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.1 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 1.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.5 | GO:0043409 | negative regulation of MAPK cascade(GO:0043409) |
0.1 | 0.8 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.4 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 1.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 3.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 7.1 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.1 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 1.6 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 1.7 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.6 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 3.7 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.1 | 0.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.1 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.7 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 3.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 1.6 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.4 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.2 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.6 | GO:0032196 | transposition(GO:0032196) |
0.1 | 1.8 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 0.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.2 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.5 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.1 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 0.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 4.0 | GO:0044839 | cell cycle G2/M phase transition(GO:0044839) |
0.1 | 2.9 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
0.1 | 0.1 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.1 | 0.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 2.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.4 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.1 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.1 | 0.2 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 2.8 | GO:0046323 | glucose import(GO:0046323) |
0.1 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 2.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 1.0 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.8 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.1 | 0.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 1.5 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.8 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.1 | 1.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 1.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 1.8 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 0.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 1.9 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.3 | GO:0034475 | U4 snRNA 3'-end processing(GO:0034475) |
0.1 | 1.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.3 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.3 | GO:0032094 | response to food(GO:0032094) |
0.1 | 1.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 1.9 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.2 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
0.1 | 1.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.2 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.5 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.1 | 0.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 5.5 | GO:0050673 | epithelial cell proliferation(GO:0050673) |
0.1 | 8.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 1.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.3 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 2.4 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0046425 | regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 0.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 7.7 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.1 | 2.7 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.1 | 0.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.2 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.3 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.1 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.5 | GO:0009411 | response to UV(GO:0009411) |
0.1 | 0.9 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 3.8 | GO:0048675 | axon extension(GO:0048675) |
0.1 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.2 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.2 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.4 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.6 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.1 | 0.1 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.1 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.1 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.5 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 0.2 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.5 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 1.0 | GO:0001667 | ameboidal-type cell migration(GO:0001667) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.5 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 1.5 | GO:0046467 | membrane lipid biosynthetic process(GO:0046467) |
0.1 | 0.1 | GO:0060921 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.1 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 1.3 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.1 | 0.7 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 0.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.1 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.1 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.3 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.3 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 0.6 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.1 | 1.0 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.2 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.1 | 0.1 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.1 | 0.7 | GO:0006096 | glycolytic process(GO:0006096) |
0.1 | 0.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.7 | GO:0032680 | regulation of tumor necrosis factor production(GO:0032680) |
0.1 | 0.3 | GO:0003170 | heart valve development(GO:0003170) |
0.1 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 3.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.4 | GO:0014013 | regulation of gliogenesis(GO:0014013) |
0.1 | 0.2 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.1 | GO:0046164 | alcohol catabolic process(GO:0046164) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 1.8 | GO:0090132 | epithelium migration(GO:0090132) |
0.1 | 1.8 | GO:1902593 | protein import into nucleus(GO:0006606) protein targeting to nucleus(GO:0044744) single-organism nuclear import(GO:1902593) |
0.1 | 2.7 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.8 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.2 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) |
0.1 | 0.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 0.1 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.1 | 0.2 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.6 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 4.6 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.1 | 0.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.2 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.2 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.1 | 0.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.6 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.1 | GO:0051170 | nuclear import(GO:0051170) |
0.1 | 0.2 | GO:0006664 | glycolipid metabolic process(GO:0006664) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.1 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.1 | GO:1903509 | liposaccharide metabolic process(GO:1903509) |
0.1 | 0.1 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 6.1 | GO:0007283 | spermatogenesis(GO:0007283) |
0.1 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.1 | GO:0031649 | heat generation(GO:0031649) |
0.1 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.0 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.0 | 0.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.3 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.0 | 0.3 | GO:0050802 | circadian sleep/wake cycle, sleep(GO:0050802) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.0 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.0 | GO:0036314 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.0 | 0.2 | GO:0019068 | virion assembly(GO:0019068) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.0 | 0.0 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 3.3 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 0.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 1.6 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.1 | GO:0048304 | regulation of isotype switching to IgG isotypes(GO:0048302) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.3 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
0.0 | 0.1 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.0 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.1 | GO:0060538 | skeletal muscle organ development(GO:0060538) |
0.0 | 0.2 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
0.0 | 0.3 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.2 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.0 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) |
0.0 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.1 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 2.5 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.0 | 0.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 1.1 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.0 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.0 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.1 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.0 | 0.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.2 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.0 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.0 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.0 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.7 | GO:0071560 | cellular response to transforming growth factor beta stimulus(GO:0071560) |
0.0 | 0.0 | GO:0051970 | negative regulation of action potential(GO:0045759) negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.2 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.0 | 0.6 | GO:0022409 | positive regulation of cell-cell adhesion(GO:0022409) |
0.0 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.0 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.0 | 0.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.3 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 1.7 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0048313 | Golgi inheritance(GO:0048313) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.1 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.0 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.0 | 0.0 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.2 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.0 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.0 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.0 | 0.0 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.0 | 0.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0034103 | regulation of tissue remodeling(GO:0034103) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.0 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.0 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.0 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.2 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.0 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.1 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.0 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.8 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.1 | GO:0015918 | sterol transport(GO:0015918) |
0.0 | 0.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.0 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.1 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.0 | 0.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 2.2 | GO:0006897 | endocytosis(GO:0006897) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.0 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.0 | 0.0 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.0 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.0 | 0.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.8 | 35.5 | GO:0044393 | microspike(GO:0044393) |
10.7 | 32.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
4.9 | 43.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
4.8 | 23.9 | GO:0008091 | spectrin(GO:0008091) |
3.7 | 7.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.2 | 3.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
3.0 | 8.9 | GO:0097513 | myosin II filament(GO:0097513) |
2.7 | 8.2 | GO:0016600 | flotillin complex(GO:0016600) |
2.6 | 128.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
2.5 | 25.1 | GO:0060091 | kinocilium(GO:0060091) |
2.4 | 31.8 | GO:0001891 | phagocytic cup(GO:0001891) |
2.4 | 26.3 | GO:0031143 | pseudopodium(GO:0031143) |
2.4 | 7.1 | GO:0005745 | m-AAA complex(GO:0005745) |
2.3 | 16.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.9 | 9.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.8 | 5.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.8 | 9.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.8 | 130.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.7 | 5.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.7 | 6.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.6 | 7.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.6 | 9.4 | GO:0045180 | basal cortex(GO:0045180) |
1.4 | 6.9 | GO:0089701 | U2AF(GO:0089701) |
1.3 | 5.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
1.3 | 6.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.3 | 5.3 | GO:0072487 | MSL complex(GO:0072487) |
1.2 | 4.9 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
1.2 | 1.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.2 | 2.3 | GO:0012505 | endomembrane system(GO:0012505) |
1.2 | 6.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.1 | 4.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.1 | 13.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.1 | 9.0 | GO:0001520 | outer dense fiber(GO:0001520) |
1.1 | 3.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.1 | 49.8 | GO:0032587 | ruffle membrane(GO:0032587) |
1.1 | 5.4 | GO:0043219 | lateral loop(GO:0043219) |
1.1 | 8.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.0 | 4.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.0 | 1.9 | GO:0042585 | germinal vesicle(GO:0042585) |
0.9 | 9.4 | GO:0099738 | cell cortex region(GO:0099738) |
0.9 | 9.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.9 | 4.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 5.6 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.9 | 0.9 | GO:0097458 | neuron part(GO:0097458) |
0.9 | 1.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.9 | 14.8 | GO:0043034 | costamere(GO:0043034) |
0.9 | 51.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.9 | 5.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.9 | 3.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.9 | 3.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.9 | 2.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.9 | 10.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.9 | 32.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.9 | 2.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.9 | 41.2 | GO:0016459 | myosin complex(GO:0016459) |
0.8 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.8 | 2.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.8 | 2.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.8 | 13.0 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.8 | 4.9 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.8 | 1.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.8 | 1.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.8 | 6.3 | GO:0034464 | BBSome(GO:0034464) |
0.7 | 4.4 | GO:0071437 | invadopodium(GO:0071437) |
0.7 | 5.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.7 | 2.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.7 | 1.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.7 | 21.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 6.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.7 | 31.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.6 | 1.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 1.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.6 | 6.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.6 | 1.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.6 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.6 | 1.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 1.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 17.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.6 | 2.9 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 5.2 | GO:0005694 | chromosome(GO:0005694) |
0.6 | 1.7 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.6 | 2.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.6 | 5.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.6 | 5.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.6 | 4.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.6 | 2.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 3.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.6 | 1.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 6.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 2.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 31.3 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 1.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 10.1 | GO:0032420 | stereocilium(GO:0032420) |
0.5 | 7.4 | GO:0030057 | desmosome(GO:0030057) |
0.5 | 2.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 0.5 | GO:1990696 | USH2 complex(GO:1990696) |
0.5 | 15.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.5 | 2.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 1.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.5 | 8.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 9.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.5 | 2.4 | GO:0043025 | neuronal cell body(GO:0043025) |
0.5 | 7.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 1.9 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 4.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.5 | 3.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 6.1 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 12.9 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 4.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 1.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 3.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 0.4 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.4 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 5.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 2.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.4 | 20.1 | GO:0001726 | ruffle(GO:0001726) |
0.4 | 3.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.4 | 1.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 4.1 | GO:0043218 | compact myelin(GO:0043218) |
0.4 | 6.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 2.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.4 | 6.9 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 13.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 56.3 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.4 | 8.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.4 | 1.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 2.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 1.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 3.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 4.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.4 | 0.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 2.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 8.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 1.5 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 6.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 0.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 10.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 4.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.3 | 1.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 1.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 8.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 4.1 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.3 | 9.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 1.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 2.7 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 2.0 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 6.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 7.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 1.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 10.4 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 0.6 | GO:0042827 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.3 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 22.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.3 | 7.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 1.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 0.9 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 2.8 | GO:0002102 | podosome(GO:0002102) |
0.3 | 2.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 3.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 5.8 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 2.7 | GO:0005903 | brush border(GO:0005903) |
0.3 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 3.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 0.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 8.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 13.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 5.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 3.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 11.5 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 1.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 4.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 1.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.3 | 3.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 4.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 5.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 0.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 0.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 1.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 4.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 1.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 2.8 | GO:0005675 | holo TFIIH complex(GO:0005675) carboxy-terminal domain protein kinase complex(GO:0032806) |
0.3 | 2.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 2.2 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 0.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 6.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.3 | 2.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 0.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 1.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 0.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 0.5 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 5.8 | GO:0042995 | cell projection(GO:0042995) |
0.3 | 1.0 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.3 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 2.4 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 14.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 2.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 15.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 4.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 1.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 10.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 1.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 54.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 6.6 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.2 | 0.7 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 10.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 2.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 2.2 | GO:0031672 | A band(GO:0031672) |
0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 6.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 2.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 6.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 5.2 | GO:0030018 | Z disc(GO:0030018) |
0.2 | 2.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 2.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 1.0 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 6.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 0.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 6.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 1.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 3.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 6.1 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.6 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 2.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 18.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 2.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 36.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 2.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 7.2 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 5.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 3.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 181.8 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.3 | GO:0070820 | specific granule(GO:0042581) tertiary granule(GO:0070820) |
0.2 | 0.8 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 3.9 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 1.6 | GO:0005901 | caveola(GO:0005901) |
0.2 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 5.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 3.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 190.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 1.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 2.2 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 4.0 | GO:0031514 | motile cilium(GO:0031514) |
0.2 | 0.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 1.3 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.3 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 1.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 3.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 4.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.4 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 0.8 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 4.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 5.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 6.0 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.2 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.9 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 2.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 8.1 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 3.9 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.8 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 8.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 135.9 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.1 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.7 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 2.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 3.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 8.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 1.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.2 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 3.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 196.3 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 2.1 | GO:0097223 | sperm part(GO:0097223) |
0.1 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.3 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 2.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 2.4 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.1 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.3 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.6 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.0 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 55.8 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 95.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.0 | GO:0098805 | whole membrane(GO:0098805) |
0.0 | 4.5 | GO:0005576 | extracellular region(GO:0005576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.4 | 101.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
6.5 | 45.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
5.3 | 69.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
4.0 | 15.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
3.9 | 42.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
3.8 | 11.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
3.8 | 11.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
3.6 | 25.5 | GO:0030957 | Tat protein binding(GO:0030957) |
3.5 | 10.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
3.3 | 104.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
3.2 | 9.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.1 | 12.6 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.9 | 14.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.8 | 2.8 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
2.6 | 7.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.4 | 36.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
2.4 | 7.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.4 | 9.4 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
2.3 | 11.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
2.2 | 13.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
2.0 | 23.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
1.9 | 5.8 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.9 | 5.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.9 | 5.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.8 | 10.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.8 | 5.3 | GO:0004103 | choline kinase activity(GO:0004103) |
1.8 | 14.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.7 | 15.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.7 | 5.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.6 | 4.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.6 | 16.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.6 | 4.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.6 | 6.3 | GO:0018649 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.6 | 10.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.5 | 9.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.5 | 6.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.4 | 7.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.4 | 4.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.4 | 4.2 | GO:0008142 | oxysterol binding(GO:0008142) |
1.3 | 6.7 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.3 | 4.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.3 | 2.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.3 | 6.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.2 | 2.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.2 | 3.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.2 | 3.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.2 | 5.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.2 | 9.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.2 | 8.1 | GO:0050700 | CARD domain binding(GO:0050700) |
1.2 | 24.2 | GO:0030332 | cyclin binding(GO:0030332) |
1.1 | 9.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.1 | 3.4 | GO:0019862 | IgA binding(GO:0019862) |
1.1 | 13.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.1 | 36.9 | GO:0015485 | cholesterol binding(GO:0015485) |
1.1 | 8.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.1 | 3.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.1 | 3.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.1 | 5.4 | GO:0017040 | ceramidase activity(GO:0017040) |
1.1 | 19.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.1 | 4.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.1 | 4.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.1 | 4.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 5.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.0 | 40.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.0 | 1.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.0 | 3.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.0 | 3.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.0 | 10.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.0 | 110.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
1.0 | 7.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.0 | 7.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.0 | 6.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.9 | 3.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.9 | 1.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.9 | 0.9 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.9 | 15.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.9 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.9 | 3.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.9 | 2.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 3.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.9 | 5.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.9 | 2.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.9 | 2.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.9 | 4.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.9 | 6.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.9 | 3.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 9.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.8 | 5.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.8 | 7.5 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.8 | 4.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.8 | 2.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.8 | 2.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.8 | 5.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 3.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.8 | 39.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.8 | 1.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.7 | 4.5 | GO:0015288 | porin activity(GO:0015288) |
0.7 | 11.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 7.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.7 | 39.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.7 | 2.8 | GO:0008430 | selenium binding(GO:0008430) |
0.7 | 7.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 1.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.7 | 3.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.7 | 3.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.7 | 3.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.7 | 2.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.7 | 12.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.7 | 3.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.7 | 2.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.7 | 2.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 2.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 12.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.7 | 4.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.7 | 3.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 9.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 5.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 3.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 5.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.6 | 3.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 1.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.6 | 1.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.6 | 4.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.6 | 3.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.6 | 3.0 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.6 | 1.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 8.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 9.6 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.6 | 3.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 4.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 2.9 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 1.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.6 | 1.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.6 | 2.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.6 | 1.7 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.6 | 5.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 2.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 2.8 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.6 | 1.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.6 | 5.0 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.6 | 4.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.5 | 3.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 110.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 4.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.5 | 6.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.5 | 3.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.5 | 2.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 8.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 4.6 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 0.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.5 | 2.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.5 | 2.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.5 | 11.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.5 | 3.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.5 | 2.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 1.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 2.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 1.4 | GO:0004096 | catalase activity(GO:0004096) |
0.5 | 2.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.5 | 0.9 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.5 | 2.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 1.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.5 | 1.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.5 | 0.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.5 | 1.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 0.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.5 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 1.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.5 | 8.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 9.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.4 | 1.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.4 | 8.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 1.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 3.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 1.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 3.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.4 | 22.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.4 | 2.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 1.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 4.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 4.3 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.4 | 11.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 1.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 2.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.4 | 3.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 61.1 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.4 | 6.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.4 | 2.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 29.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.4 | 4.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 4.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 10.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 10.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 2.8 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 3.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 1.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 33.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.4 | 1.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 5.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 0.4 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.4 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.4 | 2.3 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.4 | 2.7 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.4 | 0.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 1.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 2.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 2.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 2.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 5.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.4 | 2.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 0.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.4 | 1.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 7.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.4 | 5.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 2.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 1.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.4 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 5.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 9.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 1.4 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.3 | 0.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 2.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 1.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 1.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 7.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.3 | 0.7 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 1.0 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 0.7 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 1.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 0.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 10.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 1.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 4.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 5.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 0.6 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.3 | 2.8 | GO:0015250 | water channel activity(GO:0015250) |
0.3 | 0.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 2.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 1.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 0.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 2.5 | GO:0018855 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 7.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 5.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 0.9 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 3.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 2.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 1.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 0.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 1.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 0.3 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.3 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 3.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 3.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 0.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 2.0 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.3 | 2.3 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 0.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 1.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 1.7 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.3 | 1.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 9.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 2.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 1.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 1.9 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.3 | 16.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.3 | 7.0 | GO:0045543 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.3 | 1.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 2.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 47.8 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 2.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 6.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 1.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 1.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 6.3 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.3 | 1.8 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 3.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 2.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 4.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 1.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 7.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 1.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 6.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 5.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.2 | 0.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.2 | 1.0 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.2 | 0.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 1.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 0.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 1.0 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 3.0 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 16.3 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 2.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 2.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 1.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 1.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 1.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 1.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 63.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.7 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 1.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 2.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 0.7 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 2.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 4.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.7 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 1.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 1.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 25.9 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.2 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 5.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 2.7 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 5.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 0.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 5.3 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.2 | 2.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 4.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.2 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 1.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 1.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 1.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 5.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 12.9 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 2.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 3.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 1.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 1.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 0.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 6.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 1.5 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 0.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 4.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 1.6 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 1.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 5.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 4.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 2.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 8.8 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.2 | 1.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.5 | GO:0032564 | dATP binding(GO:0032564) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 3.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 11.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.3 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 4.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 4.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 3.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 4.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 0.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 2.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 2.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 5.5 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 2.4 | GO:0046332 | SMAD binding(GO:0046332) |
0.2 | 0.9 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 2.1 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 0.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.7 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 1.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 1.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 10.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 2.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 1.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 4.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 46.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 4.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 2.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.5 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 2.0 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.7 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 3.3 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 2.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 3.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 8.0 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 1.2 | GO:0015116 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 13.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 2.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 4.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 2.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.0 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 5.6 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 9.2 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 2.1 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.1 | 1.8 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 1.8 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 1.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 2.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 8.0 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 3.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 1.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 1.2 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.1 | 1.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 4.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 6.9 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.2 | GO:0034838 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 5.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.1 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 5.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.3 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.3 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 3.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.4 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.4 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 9.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 2.8 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.7 | GO:0031404 | voltage-gated chloride channel activity(GO:0005247) chloride ion binding(GO:0031404) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.3 | GO:0034562 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.8 | GO:0031267 | small GTPase binding(GO:0031267) |
0.1 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.8 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.7 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 2.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.9 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.1 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 23.6 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 5.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 9.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.7 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.7 | GO:0005416 | sodium:amino acid symporter activity(GO:0005283) cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.8 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.1 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 1.0 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 2.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.9 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.2 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 2.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 2.5 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 29.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.2 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 1.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.3 | GO:0043178 | alcohol binding(GO:0043178) |
0.1 | 1.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.3 | GO:0016407 | acetyltransferase activity(GO:0016407) |
0.1 | 4.2 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 29.0 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.3 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.0 | 1.6 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 5.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.2 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.0 | 0.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.2 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 1.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 1.2 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.4 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 0.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.1 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.0 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.2 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.0 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.0 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) sugar transmembrane transporter activity(GO:0051119) carbohydrate transporter activity(GO:1901476) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.2 | GO:0050997 | quaternary ammonium group binding(GO:0050997) |
0.0 | 0.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.0 | GO:0031419 | cobalamin binding(GO:0031419) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 105.2 | PID ATM PATHWAY | ATM pathway |
2.3 | 46.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
2.1 | 30.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.1 | 26.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.4 | 13.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.8 | 6.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.8 | 20.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 28.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.8 | 8.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 44.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.8 | 9.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.8 | 15.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 20.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.7 | 29.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.7 | 7.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.7 | 20.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 29.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.7 | 8.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.7 | 2.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.7 | 9.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.7 | 3.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.7 | 2.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.6 | 4.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.6 | 3.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 13.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.6 | 7.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 24.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 7.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 1.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 20.8 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 29.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.5 | 16.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 6.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 36.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 14.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 6.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 2.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 9.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 4.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 5.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 1.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 6.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 1.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 6.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 11.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 2.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 2.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 5.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 6.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 6.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 6.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 5.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 1.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 6.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 11.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 1.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 7.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 8.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 2.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 10.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 5.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 0.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 35.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 10.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 3.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 6.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 1.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 1.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 3.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 1.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 6.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 2.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 1.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 1.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 4.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 5.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 1.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 2.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 0.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 2.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 3.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 3.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 2.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 2.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.4 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 7.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 5.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 2.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 109.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
3.8 | 84.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
3.1 | 31.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
2.4 | 42.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
2.1 | 33.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.9 | 47.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.8 | 27.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.6 | 19.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.4 | 23.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.4 | 30.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.2 | 25.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.2 | 19.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.1 | 12.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.1 | 12.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.1 | 4.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.1 | 22.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.0 | 1.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.0 | 14.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.0 | 39.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.0 | 13.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.0 | 7.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.9 | 9.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.9 | 9.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 9.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.8 | 6.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.8 | 12.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.8 | 18.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 7.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.7 | 7.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 12.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.7 | 2.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.7 | 7.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.7 | 10.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.7 | 16.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 11.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.6 | 7.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.6 | 4.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 7.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.5 | 14.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 10.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 0.5 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.5 | 1.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 2.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 9.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.5 | 2.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.5 | 9.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 8.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 6.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.5 | 2.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 3.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 6.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 1.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 20.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 7.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 5.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 2.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 9.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 3.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 3.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 1.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 4.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 3.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 10.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.4 | 1.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 6.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 4.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 5.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 8.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 4.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 5.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 3.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 3.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 11.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 2.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 1.8 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.3 | 1.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 1.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 2.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 2.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.3 | 2.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 3.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 28.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 7.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 3.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 2.2 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 3.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 2.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 9.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 1.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 6.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 1.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 17.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 3.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.3 | 0.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 12.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 2.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 6.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 2.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 2.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 1.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 3.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 4.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 10.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 8.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 2.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 2.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 4.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 3.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 1.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 2.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 3.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 3.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 16.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 1.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 7.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.2 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.2 | 5.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 2.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 1.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 3.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 1.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 1.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 4.0 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 3.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 5.0 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 0.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 2.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.2 | 2.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 1.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 6.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 15.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.4 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.1 | 2.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 2.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 2.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 2.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 1.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 2.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.7 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 6.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 2.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 2.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 4.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.6 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 1.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 1.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.2 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |